FR2195430A1 - - Google Patents

Info

Publication number
FR2195430A1
FR2195430A1 FR7301948A FR7301948A FR2195430A1 FR 2195430 A1 FR2195430 A1 FR 2195430A1 FR 7301948 A FR7301948 A FR 7301948A FR 7301948 A FR7301948 A FR 7301948A FR 2195430 A1 FR2195430 A1 FR 2195430A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7301948A
Other versions
FR2195430B1 (fr
Inventor
G Tarzia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of FR2195430A1 publication Critical patent/FR2195430A1/fr
Application granted granted Critical
Publication of FR2195430B1 publication Critical patent/FR2195430B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7301948A 1972-08-07 1973-01-19 Expired FR2195430B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2795872 1972-08-07

Publications (2)

Publication Number Publication Date
FR2195430A1 true FR2195430A1 (fr) 1974-03-08
FR2195430B1 FR2195430B1 (fr) 1976-04-09

Family

ID=11222675

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7301948A Expired FR2195430B1 (fr) 1972-08-07 1973-01-19

Country Status (23)

Country Link
JP (1) JPS5030619B2 (fr)
KR (1) KR780000069B1 (fr)
AR (1) AR200007A1 (fr)
AT (1) AT322551B (fr)
AU (1) AU477231B2 (fr)
BE (1) BE794096A (fr)
CH (1) CH544105A (fr)
CS (1) CS177127B2 (fr)
DD (1) DD106387A5 (fr)
DE (1) DE2301030A1 (fr)
ES (1) ES417638A1 (fr)
FR (1) FR2195430B1 (fr)
GB (1) GB1374345A (fr)
HU (1) HU164781B (fr)
IE (1) IE36941B1 (fr)
IL (1) IL40904A (fr)
LU (1) LU66643A1 (fr)
NL (1) NL149797B (fr)
NO (1) NO137550C (fr)
RO (1) RO63442A (fr)
SE (1) SE376236B (fr)
SU (1) SU511003A3 (fr)
ZA (1) ZA728259B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD112905A5 (fr) * 1971-09-02 1975-05-12 Snam Progetti
US4110256A (en) * 1976-06-22 1978-08-29 Nippon Soken, Inc. Catalyst for reforming fuel and method for producing same
JPS59125900U (ja) * 1983-02-10 1984-08-24 マルヤス機械株式会社 組立ライン装置
DE3425118A1 (de) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue redox-indikatoren
JPS6133499U (ja) * 1984-07-30 1986-02-28 中西金属工業株式会社 電気製品製造用パレツト
CA2396738C (fr) * 1990-11-30 2006-08-29 Masatoshi Chihiro Derives du thiazole comme inhibiteur actif du radical superoxyde
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
US8946231B2 (en) 2009-03-23 2015-02-03 Merck Sharp & Dohme Corp. P2X3, receptor antagonists for treatment of pain
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
EP2634185B1 (fr) 2012-03-02 2016-01-13 Sareum Limited Inhibiteurs de la kinase TYK2
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713392A (fr) * 1967-06-14 1968-10-08 Wyeth John & Brother Ltd

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713392A (fr) * 1967-06-14 1968-10-08 Wyeth John & Brother Ltd

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS 1963 VOLUME 58, ABSTRACTS 1444D ET 904OF QUI CITENT ZH. OBSHOH.KHIM 1962 -32) *

Also Published As

Publication number Publication date
NO137550C (no) 1978-03-15
NO137550B (no) 1977-12-05
NL149797B (nl) 1976-06-15
FR2195430B1 (fr) 1976-04-09
BE794096A (fr) 1973-05-16
JPS5030619B2 (fr) 1975-10-02
JPS4945067A (fr) 1974-04-27
SE376236B (fr) 1975-05-12
GB1374345A (en) 1974-11-20
KR780000069B1 (en) 1978-03-30
AU477231B2 (en) 1976-10-21
ZA728259B (en) 1973-07-25
IL40904A0 (en) 1973-01-30
AU5698273A (en) 1974-12-19
DE2301030A1 (de) 1974-02-28
AT322551B (de) 1975-05-26
DD106387A5 (fr) 1974-06-12
IE36941B1 (en) 1977-03-30
HU164781B (fr) 1974-04-11
SU511003A3 (ru) 1976-04-15
IE36941L (en) 1974-02-07
NL7300326A (fr) 1974-02-11
IL40904A (en) 1975-12-31
AR200007A1 (es) 1974-10-15
ES417638A1 (es) 1976-02-01
RO63442A (fr) 1978-07-15
CS177127B2 (fr) 1977-07-29
LU66643A1 (fr) 1973-02-14
CH544105A (fr) 1973-11-15

Similar Documents

Publication Publication Date Title
JPS5315640B2 (fr)
FR2195430B1 (fr)
FR2192838A1 (fr)
JPS494052A (fr)
JPS5225359Y2 (fr)
FR2206211B1 (fr)
JPS4930370U (fr)
JPS4910548A (fr)
JPS4884569A (fr)
JPS4942158U (fr)
FR2191085A1 (fr)
JPS4992814U (fr)
JPS5237421Y2 (fr)
JPS532627Y2 (fr)
JPS4947798U (fr)
JPS4971061U (fr)
CH577269A5 (fr)
CH577500A5 (fr)
BG20152A1 (fr)
CH576696A5 (fr)
CH574527B5 (fr)
CH577505A5 (fr)
CH577870A5 (fr)
CH574485A5 (fr)
CH574109A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse